US Patent

US9526738 — Topical gels and methods of using the same

Formulation · Assigned to Novan Inc · Expires 2031-09-03 · 5y remaining

Vulnerability score 61/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects topical gels that comprise diazeniutndiolate-functionalized polysiloxane macromolecules and methods of using them to treat wounds and other skin ailments.

USPTO Abstract

Provided according to some embodiments of the invention are topical gels that may release nitric oxide. Also provided are methods of using such topical gels in the treatment of wounds and other skin ailments. The topical gels comprise diazeniutndiolate-functionalized polysiloxane macromolecules.

Drugs covered by this patent

berdazimer-sodium (BERDAZIMER SODIUM)

Patent Metadata

Patent number: US9526738
Jurisdiction: US
Classification: Formulation
Expires: 2031-09-03
Drug substance claim: No
Drug product claim: Yes
Assignee: Novan Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.